About: NanOlogy
Profile:
Posts by NanOlogy:
- PharmaVOICE: Next-Generation Nanomedicines (January 3, 2018 - NanOlogy in the News)
- NanOlogy to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco (January 3, 2018 - NanOlogy Press Release, Soria)
- Drug Delivery Business: NanOlogy takes nanoparticle tech into Phase II trials (December 19, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase 2 Clinical Trial of NanoPac® Adding to Trials in Prostate and Ovarian Cancers (December 18, 2017 - NanOlogy Press Release, Soria)
- Clinical Leader: Trial Aims To Kill Cancer Without Chemotherapy Side Effects (November 20, 2017 - NanOlogy in the News)
- DDNEWS: New Cancer Answer (November 13, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Mucinous Cysts of the Pancreas (November 7, 2017 - NanOlogy Press Release, Soria)
- Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery (October 16, 2017 - NanOlogy in the News)
- Journal for Clinical Studies: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer (October 16, 2017 - NanOlogy in the News)
- Drug Delivery: NanOlogy takes nanoparticle tech into phase 2 trials. (October 16, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer (October 16, 2017 - NanOlogy Press Release, Soria)
- PBR: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer (October 10, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Ovarian Cancer (October 9, 2017 - NanOlogy Press Release, Soria)
- Practical Dermatology: Update from DFB Soria on Enrollment in Phase 2 Clinical Trial of Nanoparticle Paclitaxel Ointment for AK (October 3, 2017 - NanOlogy in the News)
- DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) (September 26, 2017 - NanOlogy Press Release, Soria)
- DFB Pharmaceuticals Forms NanOlogy & Soria for Clinical Development of Naked Nanoparticle Platform (September 18, 2017 - NanOlogy in the News)
- Cancer Treatment: DFB Pharmaceuticals forms new company that could revolutionize cancer treatment (September 17, 2017 - NanOlogy in the News)
- ‘Bare’-ish on naked effort, Nanology unveils particle approach across cancers (September 17, 2017 - NanOlogy in the News)
- DFB Pharmaceuticals Forms NanOlogy™ (September 17, 2017 - NanOlogy in the News)
